Historically, clinical trials have treated all brains the same way. We know that is not how the world works. Individuals with unique blueprints—including diagnosed or self-identified autistic individuals and those with ADHD—process sensory data, emotional stress, and early childhood developmental trauma differently.
By tracking how different neurotypes respond to 5-MeO-DMT, you are helping us build a more inclusive, accurate, and effective model for future mental health treatments. Your data helps pave the way for highly tailored, somatic, and trauma-informed integration care worldwide.
To build a high-quality scientific study, consistency is everything. You will be asked to complete the exact same short questionnaire at three specific milestones over a six-month period.
We keep the questions completely identical across these intervals so we can mathematically track how your nervous system shifts from your baseline state to your long-term integration state.
Number of Questions: 15 rapid-scale questions plus 1 neurotype identifier. It takes less than 5 minutes to complete each time.
Completed on this website during your application process, before your retreat session. This establishes your starting point.
Sent via email exactly 30 days after your session. This captures the initial integration phase once the acute “glow” has settled into daily life.
Sent via email six months post-session. This is the academic gold standard. It tells us if the positive shifts in your well-being have become stable, permanent changes.
Our questionnaire is carefully divided into four distinct buckets. Here is exactly why we measure each one:
Why we track it: We look at how you process sensory environments, your tendency to “mask” or camouflage in social settings, and your cognitive style.
The Science: Autistic or ADHD nervous systems often carry a higher baseline of daily tension due to sensory overload. By identifying your unique blueprint up front, we can see if different neurotypes experience a distinct timeline of healing and integration compared to neurotypical participants.
Why we track it: We measure core indicators of mood, energy levels, and sleep patterns.
The Science: This allows us to track whether a deep, singular psychospiritual experience can break through chronic states of depressive shutdown, and whether that relief holds steady half a year later.
Why we track it: We assess states of being on edge, physical tension, and uncontrollable worry.
The Science: Fast-acting tryptamines interact heavily with the autonomic nervous system. Tracking this helps us map how the body transitions out of a chronic “fight-or-flight” state and into a state of safety.
Why we track it: We measure intrusive memories, flashbacks, hyper-vigilance, and somatic (body-based) trauma reactions.
The Science: Early childhood developmental trauma often gets locked into the body as a survival mechanism. This section tracks whether the peak experience helps decondition those deeply held trauma loops, allowing the nervous system to finally reset.
All data collected in this study is strictly confidential, securely stored, and fully anonymised before any analysis takes place. Your name and personal details will never be shared or published. Choosing to share your neurotype status or symptoms will never negatively impact your retreat application—all conditions and neurotypes are profoundly welcome, safe, and supported here.
Thank you for helping us shape the future of trauma-informed psychedelic science.
THE STUDY IS ONLY FOR PEOPLE WHO WILL ATTEND OUR RETREATS.